[1]
|
Black, R.E., et al. (2010) Global, Regional, and National Causes of Child Mortality in 2008: A Systematic Analysis. The Lancet, 375, 1969-1987. https://doi.org/10.1016/S0140-6736(10)60549-1
|
[2]
|
Florin, T.A., et al. (2018) Valida-tion of the Pediatric Infectious Diseases Society-Infectious Diseases Society of America Severity Criteria in Children with Community-Acquired Pneumonia. Clinical Infectious Diseases, 67, 112-119.
https://doi.org/10.1093/cid/ciy031
|
[3]
|
中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童社区获得性肺炎管理指南(2013修订) (上) [J]. 中华儿科杂志, 2013, 51(10): 745-752.
|
[4]
|
覃鑫, 胡量子. 重症肺炎患者降钙素原、C反应蛋白、D-二聚体的水平变化及其对预后的诊断价值[J]. 医学综述, 2020, 26(15): 3077-3081.
|
[5]
|
李雅琪, 许留刚. 血清降钙素原在婴幼儿重症肺炎早期诊断中的价值[J]. 医药论坛杂志, 2020, 41(3): 140-142.
|
[6]
|
陈敏, 简亚梅, 徐亚军, 等. 降钙素原和血清淀粉样蛋白A在重症肺炎诊疗中的价值[J]. 华夏医学, 2023, 36(4): 62-66.
|
[7]
|
Downes, K.J., Fitzgerald, J.C. and Weiss, S.L. (2020) Utility of Procalcitonin as a Biomarker for Sepsis in Children. Journal of Clinical Microbiology, 58, e01851-19. https://doi.org/10.1128/JCM.01851-19
|
[8]
|
栾军, 袁杰, 张伟利. 中性粒细胞CD64表达指数降钙素原及血清淀粉样蛋白A/超敏C-反应蛋白比值在感染性肺炎患儿诊断中的应用价值[J]. 中国妇幼保健, 2022, 37(9): 1639-1642.
|
[9]
|
兰博, 蓝桂伍, 黄华田, 等. 肺泡灌洗液降钙素原在重症肺炎中的诊断价值[J]. 医学信息, 2023, 36(11): 145-148.
|
[10]
|
Li, Y., Min, L. and Zhang, X. (2021) Usefulness of Procalcitonin (PCT), C-Reactive Protein (CRP), and White Blood Cell (WBC) Levels in the Differential Diagnosis of Acute Bacterial, Viral, and Mycoplasmal Respiratory Tract Infections in Children. BMC Pulmonary Medicine, 21, Article No. 386. https://doi.org/10.1186/s12890-021-01756-4
|
[11]
|
中华医学会儿科学分会医院感染管理与控制专业委员会. 血清降钙素原检测在儿童感染性疾病中的临床应用专家共识[J]. 中华儿科杂志, 2019, 57(1): 9-15.
|
[12]
|
Djordjevic, D., et al. (2018) Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators of Inflammation, 2018, Article ID: 3758068.
https://doi.org/10.1155/2018/3758068
|
[13]
|
吴显熠, 杨超. 外周血PCT、LDH、NLR在重症肺炎早期诊断及预后评估中的价值[J]. 标记免疫分析与临床, 2023, 30(7): 1118-1121, 1153.
|
[14]
|
Cataudella, E., et al. (2017) Neutro-phil-to-Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community-Acquired Pneumonia. Journal of the American Geriatrics Society, 65, 1796-1801.
https://doi.org/10.1111/jgs.14894
|
[15]
|
Wu, L. and Liu, B. (2021) The Clinical Effect of a Bronchofiberscope in Treating Severe Ventilator-Associated Pneumonia. American Journal of Translational Research, 13, 6966-6972.
|
[16]
|
Forget, P., et al. (2017) What Is the Normal Value of the Neutrophil-to-Lymphocyte Ratio? BMC Re-search Notes, 10, Article No. 12. https://doi.org/10.1186/s13104-016-2335-5
|
[17]
|
蒋伟燕, 李航逸, 瞿晓晓, 等. 中性粒细胞/淋巴细胞比值在儿童重症肺炎中的诊断价值[J]. 中国卫生检验杂志, 2022, 32(11): 1330-1333.
|
[18]
|
Lee, H., Kim, I., Kang, B.H. and Um, S.J. (2021) Prognostic Value of Serial Neutro-phil-to-Lymphocyte Ratio Measurements in Hospitalized Community-Acquired Pneumonia. PLOS ONE, 16, e0250067.
https://doi.org/10.1371/journal.pone.0250067
|
[19]
|
Altas, O.F. and Kizilkaya, M. (2021) The Effects of Neutro-phil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Prognostic Markers in Determining the Mortality in Patients Di-agnosed with Pneumonia in Intensive Care. Medeniyet Medical Journal, 36, 130-137. https://doi.org/10.5222/MMJ.2021.64160
|
[20]
|
Qu, R., et al. (2020) Platelet-to-Lymphocyte Ratio Is Associated with Prognosis in Patients with Coronavirus Disease-19. Journal of Medical Virology, 92, 1533-1541. https://doi.org/10.1002/jmv.25767
|
[21]
|
Kartal, O. and Kartal, A.T. (2017) Value of Neutrophil to Lymphocyte and Platelet to Lymphocyte Ratios in Pneumonia. Bratislava Medical Journal, 118, 513-516. https://doi.org/10.4149/BLL_2017_099
|
[22]
|
惠晓霞, 王琪, 张文乾. 重症肺炎患儿血清IL-1R1、APC、sICAM-1、NLR及PLR的变化及其临床意义[J]. 实验与检验医学, 2019, 37(3): 465-467, 495.
|
[23]
|
Ren, Q., et al. (2021) The Role of Red Blood Cell Distribution Width in the Severity and Prognosis of Community-Acquired Pneumo-nia. Canadian Respiratory Journal, 2021, Article ID: 8024024.
https://doi.org/10.1155/2021/8024024
|
[24]
|
Chen, L., Lu, X.Y. and Zhu, C.Q. (2020) Prognostic Value of Albu-min-Red Cell Distribution Width Score in Patients with Severe Community-Acquired Pneumonia. Annals of Palliative Medicine, 9, 759-765.
https://doi.org/10.21037/apm.2020.04.22
|
[25]
|
裴学勇, 马耀, 任节, 等. 红细胞分布宽度对重症肺炎预后评估的临床价值[J]. 内科急危重症杂志, 2018, 24(3): 226-229.
|
[26]
|
Lee, S.M., et al. (2016) The Clinical Significance of Changes in Red Blood Cell Distribution Width in Patients with Community-Acquired Pneumonia. Clinical and Experi-mental Emergency Medicine, 3, 139-147.
https://doi.org/10.15441/ceem.15.081
|
[27]
|
Hirano, T. (2021) IL-6 in Inflammation, Autoimmunity and Cancer. In-ternational Immunology, 33, 127-148.
https://doi.org/10.1093/intimm/dxaa078
|
[28]
|
Andrijevic, I., et al. (2014) Interleukin-6 and Procalcitonin as Bi-omarkers in Mortality Prediction of Hospitalized Patients with Community Acquired Pneumonia. Annals of Thoracic Medicine, 9, 162-167.
https://doi.org/10.4103/1817-1737.134072
|
[29]
|
Liu, F., et al. (2020) Prognostic Value of Interleukin-6, C-Reactive Protein, and Procalcitonin in Patients with COVID-19. Journal of Clinical Virology, 127, Article ID: 104370. https://doi.org/10.1016/j.jcv.2020.104370
|
[30]
|
Martin-Loeches, I., et al. (2014) Predicting Treatment Failure in Pa-tients with Community Acquired Pneumonia: A Case-Control Study. Respiratory Research, 15, Article No. 75. https://doi.org/10.1186/1465-9921-15-75
|
[31]
|
Paats, M.S., et al. (2013) Local and Systemic Cytokine Profiles in Nonsevere and Severe Community-Acquired Pneumonia. European Respiratory Journal, 41, 1378-1385. https://doi.org/10.1183/09031936.00060112
|
[32]
|
张春玲, 杨远见, 刘畅, 等. 血清降钙素原、肝素结合蛋白、白细胞介素⁃6联合序贯器官衰竭评分对重症肺炎患者预后评估的意义[J]. 实用医学杂志, 2022, 38(2): 168-172.
|
[33]
|
Vasconcellos, Â.G., et al. (2018) Systemic Cytokines and Chemokines on Admission of Children Hospi-talized with Community-Acquired Pneumonia. Cytokine, 107, 1-8. https://doi.org/10.1016/j.cyto.2017.11.005
|
[34]
|
陈志敏, 张园园. 儿童肺炎病原体的实验室检查方法[J]. 中华妇幼临床医学杂志(电子版), 2014, 10(4): 448-450.
|
[35]
|
林立, 王丽, 金尾静, 等. 支原体肺炎伴喘息患儿血清细胞间黏附分子-1与白细胞介素-17A的表达[J]. 中华医院感染学杂志, 2015, 25(7): 1472-1474.
|
[36]
|
Lorenzo, M.J., et al. (2015) Lung Inflammatory Pattern and Antibiotic Treatment in Pneumonia. Respiratory Research, 16, Article No. 15. https://doi.org/10.1186/s12931-015-0165-y
|
[37]
|
林洪远, 郭旭生, 姚咏明, 等. CD+14单核细胞人类白细胞抗原-DR预测脓毒症预后及指导免疫调理治疗的初步临床研究[J]. 中国危重病急救医学, 2003, 15(3): 135-138.
|
[38]
|
Almeida-Oliveira, A., et al. (2011) Age-Related Changes in Natural Killer Cell Receptors from Childhood through Old Age. Human Immunology, 72, 319-329. https://doi.org/10.1016/j.humimm.2011.01.009
|
[39]
|
Zhuang, Y., et al. (2015) Predicting the Outcomes of Subjects with Severe Community-Acquired Pneumonia Using Monocyte Human Leukocyte Antigen-DR. Respiratory Care, 60, 1635-1642. https://doi.org/10.4187/respcare.03953
|
[40]
|
周曙俊, 周军, 王大明. 单核细胞人白细胞抗原DR监测在重症肺炎患者预后评估中的价值[J]. 江苏大学学报(医学版), 2013, 23(1): 30-33.
|
[41]
|
李风峰, 康占旺, 曾璐, 等. 左卡尼汀辅助治疗重症肺炎伴发心力衰竭对患儿炎症细胞及T淋巴细胞水平的影响[J]. 陕西医学杂志, 2020, 49(1): 56-59.
|
[42]
|
Zhang, W., Brahmakshatriya, V. and Swain, S.L. (2014) CD4 T Cell Defects in the Aged: Causes, Consequences and Strategies to Circumvent. Experimental Gerontology, 54, 67-70. https://doi.org/10.1016/j.exger.2014.01.002
|
[43]
|
黄丹虹, 刘相圻. 清气化痰汤联合纤维支气管镜肺泡灌洗吸痰治疗重症肺炎疗效及对患者血清T淋巴细胞亚群的影响[J]. 陕西中医, 2019, 40(11): 1541-1544.
|
[44]
|
龙思琪, 马莉, 陈敏, 等. 婴幼儿重症和非重症肺炎淋巴细胞亚群的差异分析[J]. 中国免疫学杂志, 2016, 32(3): 401-404.
|
[45]
|
邓建荣, 林小芹. 婴幼儿重症肺炎免疫球蛋白、T淋巴细胞亚群的变化及临床意义[J]. 海南医学, 2018, 29(22): 3173-3176.
|
[46]
|
Martin, M.D., Badovinac, V.P. and Griffith, T.S. (2020) CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State. Frontiers in Immunology, 11, Article 1364. https://doi.org/10.3389/fimmu.2020.01364
|
[47]
|
Hohlstein, P., et al. (2019) Prognostic Relevance of Altered Lym-phocyte Subpopulations in Critical Illness and Sepsis. Journal of Clinical Medicine, 8, Article 353. https://doi.org/10.3390/jcm8030353
|
[48]
|
游正铭. 淋巴细胞亚群检测在重症肺炎治疗及预后评估中的意义[J]. 中国卫生检验杂志, 2017, 27(12): 1768-1769, 1772.
|
[49]
|
Chalmers, J.D., et al. (2009) Admission D-Dimer Can Iden-tify Low-Risk Patients with Community-Acquired Pneumonia. Annals of Emergency Medicine, 53, 633-638. https://doi.org/10.1016/j.annemergmed.2008.12.022
|
[50]
|
张黎蕾, 夏永泉, 王贤, 等. 重症肺炎患者炎症指标、免疫功能及凝血功能变化对预后的影响[J]. 南京医科大学学报(自然科学版), 2021, 41(2): 234-237.
|
[51]
|
黄彩芝, 杨龙贵, 张聪, 等. D-二聚体、N末端脑钠素原及炎症标志物与儿童重症肺炎预后的关系[J]. 临床儿科杂志, 2018, 36(10): 772-776.
|
[52]
|
Ge, Y.L., et al. (2019) Elevated Plasma D-Dimer in Adult Community-Acquired Pneumonia Pa-tients Is Associated with an Increased Inflammatory Reaction and Lower Survival. Clinical Laboratory, 65, Article ID: 30775898.
https://doi.org/10.7754/Clin.Lab.2018.180720
|
[53]
|
Wen, J., et al. (2021) The Combination of Initial Markers to Predict Refractory Mycoplasma pneumoniae Pneumonia in Chinese Children: A Case Control Study. Respiratory Re-search, 22, Article No. 89.
https://doi.org/10.1186/s12931-020-01577-9
|
[54]
|
邹映雪, 赵顺英, 刘瀚旻. 儿童重症肺炎临床预警及早期决策专家共识[J]. 中国实用儿科杂志, 2023, 38(3): 177-182.
|
[55]
|
陈巧琳, 申昆玲, 谢正德. 血清铁蛋白水平与儿童社区获得性肺炎病情严重程度的关系[J]. 中华实用儿科临床杂志, 2018, 33(10): 753-757.
|
[56]
|
Agapakis, D.I., et al. (2010) Coagulation and Inflammation Biomarkers May Help Predict the Severity of Community-Acquired Pneumonia. Respirology, 15, 796-803. https://doi.org/10.1111/j.1440-1843.2010.01773.x
|
[57]
|
马为, 高梦琦, 荆翠翠, 等. NT-pro-BNP、cTnI及PCT在心力衰竭合并重症肺炎患者中的表达及临床意义[J]. 分子诊断与治疗杂志, 2022, 14(5): 777-780.
|
[58]
|
汤炜, 许超. 重症肺炎患者血浆N末端脑钠肽前体、D-二聚体水平与炎症因子及预后的关系[J]. 国际检验医学杂志, 2020, 41(3): 297-300, 304.
|
[59]
|
Li, J., Ye, H. and Zhao, L. (2015) B-Type Natriuretic Pep-tide in Predicting the Severity of Community-Acquired Pneumonia. World Journal of Emergency Medicine, 6, 131-136.
https://doi.org/10.5847/wjem.j.1920-8642.2015.02.008
|
[60]
|
Xiao, K., et al. (2013) Analysis of the Severity and Prognosis Assessment of Aged Patients with Community-Acquired Pneumonia: A Retrospective Study. Journal of Thoracic Disease, 5, 626-633.
|